Re: Dose escalation methods in phase I cancer clinical trials.
Zohar
Sarah
S
O'Quigley
John
J
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D017321:Clinical Trials, Phase I as Topic / Q000941:ethics / Q000379:methods*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004354:Drug Screening Assays, Antitumor / Q000379:methods; D006801:Humans; D012107:Research Design / Q000592:standards / Q000639:trends
D000970:Antineoplastic Agents